PT  - JOURNAL ARTICLE
AU  - Reo Takaku
AU  - Izumi Yokoyama
TI  - Financial Meltdown in “Swing Hospitals” during the COVID-19 Outbreak
AID  - 10.1101/2021.06.06.21258442
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.06.21258442
4099  - http://medrxiv.org/content/early/2021/06/09/2021.06.06.21258442.short
4100  - http://medrxiv.org/content/early/2021/06/09/2021.06.06.21258442.full
AB  - Hospitals in Japan have complete autonomy in deciding whether to admit COVID-19 patients, similar to that of the US. Taking this into account, we estimated the effect of admitting COVID-19 patients on hospital profits, using instrumental variable (IV) regression. Using IVs related to government intervention enabled us to not only estimate the effect of admitting COVID-19 patients among “swing hospitals,” where both options (to admit or to not admit COVID-19 patients) could potentially be realized but to also evaluate the effect of government intervention on such hospitals. Our empirical results revealed that monthly profits per bed decreased by approximately JPY 600,000 (≈ USD 6,000) among swing hospitals, which is 15 times the average monthly profits in 2019. This overwhelming financial damage indicates that it would be costly for swing hospitals to treat COVID-19 patients because of their low suitability for admitting such patients. Given the implications of our main results, we propose an alternative strategy to handling surges in patients with new infectious diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported by HIAS (Hitotsubashi Institute for Advanced Study). We thank the Tokyo Metropolitan Government for generously providing data on hospitals in Tokyo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval is required for the manuscript under the standard of the ethical review board in Hitotsubashi University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are prohibited to share anyone.